FdaApplication

ANDA 208768

Back to search

Identifiers

Properties

PropertyValue
applicant_namePH HEALTH LTD
application_typeANDA
approval_date2022-05-25

Products (1)

ProductActive ingredientStrengthDosage form
POSACONAZOLEPOSACONAZOLE300MG/16.7ML (18MG/ML)SOLUTION;INTRAVENOUS

1 product